How do you pay?

How to pay the least

Ask for the cash price

Verzenio

We didn’t find one.

  1. Ask your pharmacy for Verzenio’s cash price, and one or two other pharmacies too.
  2. Verzenio’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Lilly Cares Foundation Patient Assistance Program. Note: These income limits are 300% (Group 1 Medications), 400% (Group 2 Medications), and 500% (Group 3 & 4 Medications) of 2026 Federal Poverty Guidelines. Or call 1-800-545-6962.

See if you qualify 

Compare every option

Question
Brand nameVerzenio
Authorized genericabemaciclib
Regular genericabemaciclib
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Verzenio?
The original
–
–

Brand nameThe maker’s card

Verzenio Savings Card

Savings card from Eli Lilly

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

The card takes up to $10,600 a year off your co-pay.

Sign up on enrollment.verzenio.lilly.com 

Or call 1-800-545-5979. See the offer on verzenio.lilly.com

In the maker’s words

“If eligible and commercially insured with coverage, pay as little as $0 a month with the Verzenio Savings Card…”

From the maker’s offer on verzenio.lilly.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Verzenio itself, from the same company, sold without the brand name, and usually for less. For now Verzenio is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

VERZENIO® is a kinase inhibitor indicated:

  • in combination with endocrine therapy (tamoxifen or an aromatase inhibitor) for the adjuvant treatment of adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer at high risk of recurrence.
  • in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of adults with HR-positive, HER2-negative advanced or metastatic breast cancer.
  • in combination with fulvestrant for the treatment of adults with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy.
  • in combination with imlunestrant for the treatment of adults with estrogen receptor (ER)-positive, HER2-negative, estrogen receptor-1 (ESR1)-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy.
  • as monotherapy for the treatment of adults with HR-positive, HER2-negative advanced or metastatic breast cancer with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting.

Source: the FDA label for Verzenio (Eli Lilly and Company), September 18, 2026. Full label on DailyMed 

Good to know